Mike Tuffin is set to become AHIP's President and CEO from January 8, 2024, succeeding Julie Simon Miller.
Beginning January 8, 2024, Mike Tuffin, MBA, will take on the role of president and CEO of AHIP.
Tuffin is succeeding Matthew Eyles, who led the health insurance industry's trade group for five years before stepping down in September 2023. Julie Simon Miller, AHIP’s general counsel, served as the interim CEO.
Tuffin has been the senior vice president for external affairs for UnitedHealth Group since 2015. He is coming back to AHIP having served as executive vice president for public affairs of the organization from 2003 to 2012.
Tuffin's leadership will improve the organization’s mission of representing over 100 diverse companies providing healthcare coverage for millions of consumers and families, according to an AHIP news release about selection of Tuffin.
The chair of AHIP’s Board of Directors, David Holmberg, mentioned in the press release that the search for the position was thorough when trying to find a “forward-looking leader and advocate with extensive healthcare experience.”
“As a corporate executive, association leader and consultant, Mike has demonstrated an ability to successfully lead teams, partner with key stakeholders and advance policy outcomes that are critical to the health and security of the people our industry serves,” Holmberg said.
“Millions of American families and employers count on AHIP’s members for their coverage and care and for support in navigating our complex health care system,” Tuffin said in the press release. “I am honored to join Julie and the high-performing AHIP team in advancing this critical work.”
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Leadership Team at The Cigna Group Revamps in Efforts to Drive Growth, Enhance Customer Focus
March 13th 2025David M. Cordani, chairman and CEO of The Cigna Group, expressed that these moves were made to “build upon our strengths for continued growth, enhance our customer focus, and deliver even greater value for those we serve."
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Navitus to Offer Unbranded Stelara Biosimilar, Remove Stelara from Formulary
March 13th 2025Lumicera Health Services, Navitus’ specialty pharmacy, has made a deal with Teva to offer an unbranded biosimilar that they estimate will save $112,000 and $336,000 per patient per year. Navitus will remove Stelara from formulary on July 1, 2025.
Read More